Boyd Watterson Asset Management’s Quest Diagnostics DGX Stock Holding History

Boyd Watterson Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.75K	Hold	13	–	–	﹤0.01%	344
2026 Q1	$2.55K	Hold	13	–	–	﹤0.01%	340
2025 Q4	$2.26K	Hold	13	–	–	﹤0.01%	377
2025 Q3	$2.48K	Hold	13	–	–	﹤0.01%	370
2025 Q2	$2.33K	Hold	13	–	–	﹤0.01%	375
2025 Q1	$2.2K	Hold	13	–	–	﹤0.01%	381
2024 Q4	$1.96K	Hold	13	–	–	﹤0.01%	392
2024 Q3	$2.02K	Hold	13	–	–	﹤0.01%	393
2024 Q2	$1.78K	Hold	13	–	–	﹤0.01%	402
2024 Q1	$1.73K	Hold	13	–	–	﹤0.01%	400
2023 Q4	$1.79K	Hold	13	–	–	﹤0.01%	382
2023 Q3	$1.58K	Hold	13	–	–	﹤0.01%	382
2023 Q2	$1.83K	Hold	13	–	–	﹤0.01%	378
2023 Q1	$1.84K	Hold	13	–	–	﹤0.01%	378
2022 Q4	$2.03K	Buy	+13	New	+$1.87K	﹤0.01%	375

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Boyd Watterson Asset Management's DGX Position: Q2 2026 in Review

Boyd Watterson Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 13 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #344.

Boyd Watterson Asset Management first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Boyd Watterson Asset Management held 13 shares of Quest Diagnostics worth $2.75K as of Q2 2026.
Boyd Watterson Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up ﹤0.01% of Boyd Watterson Asset Management's portfolio in Q2 2026, its #344 holding.
Boyd Watterson Asset Management first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Boyd Watterson Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.